KU 2019 Post San Antonio Breast Cancer Review
SABCS 2019 Highlights on IO in mTNB: IMpassion130 Suggest PD-L1+ Pts Have Better Outcomes w/ Atezolizumab+Chemo, SAFIRO2-IMMUNO Suggests Durvalumab Improves OS
Login to view comments.
Click here to Login
Videos